Opportunity Information: Apply for RFA MH 22 150
This NIH funding opportunity (RFA-MH-22-150; CFDA 93.242) supports research that strengthens established adolescent mental health treatments by layering in Just-in-Time Adaptive Interventions (JITAIs). The core idea is to take treatments that already have evidence behind them (for example, well-supported psychotherapies or structured behavioral interventions) and make them more potent, timely, and engaging for teenagers by delivering adaptive support in the moments it is most needed. The mechanism is an R61/R33 phased innovation award and it is a clinical trial required announcement, meaning applicants are expected to propose and carry out a clinical trial as part of the project, with an initial developmental/feasibility phase (R61) that can transition to a larger, more confirmatory phase (R33) if predefined milestones are met.
The scientific rationale is grounded in why adolescence is such a strategic window for this work. Adolescence is a period when many mental disorders first appear or worsen, when engagement and retention in traditional face-to-face care can be difficult, and when day-to-day technology use is extremely high. The FOA is essentially betting that real-time, technology-delivered supports can help close common gaps in adolescent care: missed appointments, limited between-session practice, low motivation, and the mismatch between what is taught in session and what happens in real-world contexts like school, home, peer situations, or online spaces. By focusing on developmentally informed and theoretically grounded approaches, NIH is signaling that proposals should not just be tech-forward, but should clearly explain the behavioral or clinical theory behind what the JITAI delivers, when it delivers it, and why that should improve outcomes.
JITAIs, as described here, are meant to capitalize on near-ubiquitous device access to deliver intervention content through platforms adolescents may find intrinsically motivating, and to do so in a way that is context-sensitive and personalized. In practice, that can include prompting brief skills practice in the situations where symptoms show up, using sensors or self-report check-ins to detect risk states, tailoring messages or micro-interventions to the adolescents current needs and preferences, and providing immediate feedback, reinforcement, or coaching. The FOA highlights several functions these systems can serve: helping adolescents practice skills in ecologically valid settings (not just in the clinic), adapting intensity or type of support moment-to-moment, and offering real-time scaffolding to reduce impairment as challenges arise. It also reflects the view that recent advances in mobile computing, wearables, and digital phenotyping make these designs more feasible than they were even a few years ago.
A notable point in the announcement is the stated evidence gap: despite promising results for JITAIs in other areas such as general health behavior change and addiction, there were no published studies of JITAIs for adolescent mental disorders at the time of the FOA description. That gap is part of what NIH is trying to address, positioning this as an emerging area of intervention science rather than an incremental improvement on an already mature evidence base. In other words, applications are expected to push the field forward by demonstrating how JITAIs can be integrated with established adolescent treatments and by generating clinical trial evidence on whether those enhancements improve engagement, skill use, symptoms, functioning, or other meaningful outcomes.
In terms of logistics and eligibility, this is a discretionary grant from the National Institutes of Health. The closing date listed in the source data is 2023-01-13, and the opportunity record was created 2021-11-15. A wide range of applicant organizations are eligible, including state, county, city, and special district governments; independent school districts; public and state-controlled institutions of higher education; private institutions of higher education; federally recognized tribal governments and other tribal organizations; public housing authorities/Indian housing authorities; nonprofits with or without 501(c)(3) status; for-profit organizations (other than small businesses) and small businesses; and other entities. The FOA also explicitly calls out additional eligible applicants such as Alaska Native and Native Hawaiian Serving Institutions, AANAPISIs, Hispanic-serving Institutions, HBCUs, Tribally Controlled Colleges and Universities, faith-based or community-based organizations, certain tribal governments that are not federally recognized, U.S. territories or possessions, and even non-U.S. (foreign) organizations and regional organizations. The award ceiling and expected number of awards are not specified in the provided source fields, so applicants would typically need to consult the full FOA text for budget structure, milestone expectations, and review criteria tied to the R61/R33 transition.
Overall, the opportunity is aimed at teams that can combine clinical expertise in adolescent mental health, strong grounding in behavior change or clinical theory, and rigorous experimental methods with the technical ability to build and evaluate adaptive, real-time digital supports. The goal is not to replace established treatments, but to optimize them by extending their reach into the daily lives of adolescents, increasing timely skill delivery and practice, and improving outcomes through personalized, in-the-moment intervention components tested within a clinical trial framework.Apply for RFA MH 22 150
- The National Institutes of Health in the health sector is offering a public funding opportunity titled "Using Just-in-Time Adaptive Interventions to Optimize Established Adolescent Mental Health Treatments (R61/R33 Clinical Trial Required)" and is now available to receive applicants.
- Interested and eligible applicants and submit their applications by referencing the CFDA number(s): 93.242.
- This funding opportunity was created on 2021-11-15.
- Applicants must submit their applications by 2023-01-13. (Agency may still review applications by suitable applicants for the remaining/unused allocated funding in 2026.)
- Eligible applicants include: State governments, County governments, City or township governments, Special district governments, Independent school districts, Public and State controlled institutions of higher education, Native American tribal governments (Federally recognized), Public housing authorities/Indian housing authorities, Native American tribal organizations (other than Federally recognized tribal governments), Nonprofits having a 501 (c) (3) status with the IRS, other than institutions of higher education, Nonprofits that do not have a 501 (c) (3) status with the IRS, other than institutions of higher education, Private institutions of higher education, For-profit organizations other than small businesses, Small businesses, Others.
[Watch] Creating a grant proposal using the step-by-step wizard inside the applicant portal:
Browse more opportunities from the same agency: National Institutes of Health
Browse more opportunities from the same category: Health
Next opportunity: NHLBI SBIR Phase IIB Small Market Awards to Accelerate the Commercialization of Technologies for Heart, Lung, Blood, and Sleep Disorders and Diseases (R44 Clinical Trial Optional)
Previous opportunity: Specialty Crop Research Initiative
Applicant Portal:
Are you interested in learning about about how to apply for this government funding opportunity? You can create a free applicant account and receive instant access to our applicant portal that many business owners like you have benefited from.
Apply for RFA MH 22 150
Applicants also applied for:
Applicants who have applied for this opportunity (RFA MH 22 150) also looked into and applied for these:
| Funding Opportunity |
|---|
| Understanding Place-Based Health Inequalities in Mid-Life (R01 Clinical Trial Not Allowed) Apply for RFA AG 23 004 Funding Number: RFA AG 23 004 Agency: National Institutes of Health Category: Health Funding Amount: $400,000 |
| NHLBI SBIR Phase IIB Small Market Awards to Accelerate the Commercialization of Technologies for Heart, Lung, Blood, and Sleep Disorders and Diseases (R44 Clinical Trial Optional) Apply for RFA HL 23 008 Funding Number: RFA HL 23 008 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Patient-Clinician Relationship: Improving Health Outcomes in Populations that Experience Health Care Disparities (R01 Clinical Trial Optional) Apply for PAR 22 064 Funding Number: PAR 22 064 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Age-related Macular Degeneration (AMD) Integrative Biology Initiative: Discovery of AMD Pathobiology using Patient-Derived Induced Pluripotent Stem Cell (iPSC)-derived Retinal Pigment Epithelium (RPE) (U01 Clinical Trial Not Allowed) Apply for RFA EY 21 002 Funding Number: RFA EY 21 002 Agency: National Institutes of Health Category: Health Funding Amount: $250,000 |
| Expert-Driven Small Projects to Strengthen Gabriella Miller Kids First Discovery (R03 Clinical Trial Not Allowed) Apply for RFA RM 22 006 Funding Number: RFA RM 22 006 Agency: National Institutes of Health Category: Health Funding Amount: $100,000 |
| Basic Neurodevelopmental Biology of Circuits and Behavior (R01 Clinical Trial Not Allowed) Apply for PAR 22 066 Funding Number: PAR 22 066 Agency: National Institutes of Health Category: Health Funding Amount: $500,000 |
| Network for Emergency Care Clinical Trials: Strategies to Innovate EmeRgENcy Care Clinical Trials Network (SIREN) - Network Clinical Center (Hub) (U24 Clinical Trial Not Allowed) Apply for RFA NS 22 015 Funding Number: RFA NS 22 015 Agency: National Institutes of Health Category: Health Funding Amount: $250,000 |
| Limited Competition: Network for Emergency Care Clinical Trials: Strategies to Innovate EmeRgENcy Care Clinical Trials Network (SIREN) - Clinical Coordinating Center (CCC) (U24 Clinical Trial Not Allowed) Apply for RFA NS 22 014 Funding Number: RFA NS 22 014 Agency: National Institutes of Health Category: Health Funding Amount: $490,000 |
| NHLBI SBIR Phase IIB Bridge Awards to Accelerate the Commercialization of Technologies for Heart, Lung, Blood, and Sleep Disorders and Diseases (R44 Clinical Trial Optional) Apply for RFA HL 23 009 Funding Number: RFA HL 23 009 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Basic Neurodevelopmental Biology of Circuits and Behavior (R21 Clinical Trial Not Allowed) Apply for PAR 22 067 Funding Number: PAR 22 067 Agency: National Institutes of Health Category: Health Funding Amount: $275,000 |
| Limited Competition: Network for Emergency Care Clinical Trials: Strategies to Innovate EmeRgENcy Care Clinical Trials Network (SIREN) - Data Coordinating Center (DCC) (U24 Clinical Trial Not Allowed) Apply for RFA NS 22 013 Funding Number: RFA NS 22 013 Agency: National Institutes of Health Category: Health Funding Amount: $290,000 |
| NIGMS National and Regional Resources (R24 - Clinical Trial Not Allowed) Apply for PAR 22 065 Funding Number: PAR 22 065 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Resource Networks for Protein Polymorphisms in Alzheimers Disease and its Related Dementias (AD/ADRD) (U24 Clinical Trial Not Allowed) Apply for RFA AG 22 030 Funding Number: RFA AG 22 030 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Continuation or Revision of NIDCR Clinical Trial Implementation Cooperative Agreement (UH3 Clinical Trial Required) Apply for PAR 22 068 Funding Number: PAR 22 068 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Limited Competition: Research Resource for the National Swine Resource and Research Center (U42 Clinical Trial Not Allowed) Apply for PAR 21 356 Funding Number: PAR 21 356 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Supporting Talented Early Career Researchers in Genomics (R01 Clinical Trial Optional) Apply for RFA HG 22 001 Funding Number: RFA HG 22 001 Agency: National Institutes of Health Category: Health Funding Amount: $500,000 |
| Promoting Results and Outcomes through Policy and Economic Levers (PROPEL) Apply for 7200AA22APS00002 Funding Number: 7200AA22APS00002 Agency: Agency for International Development Category: Health Funding Amount: $180,000,000 |
| Ocular Surface Innervation from Cell Types to Circuit Functions (U01 Clinical Trial Not Allowed) Apply for RFA EY 21 004 Funding Number: RFA EY 21 004 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Technology Development to Reduce Health Disparities (R01 Clinical Trial Optional) Apply for RFA EB 21 001 Funding Number: RFA EB 21 001 Agency: National Institutes of Health Category: Health Funding Amount: $500,000 |
| Research Centers in Minority Institutions (RCMI) (U54 Clinical Trials Optional) Apply for RFA MD 22 002 Funding Number: RFA MD 22 002 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
Grant application guides and resources
It is always free to apply for government grants. However the process may be very complex depending on the funding opportunity you are applying for. Let us help you!
Apply for Grants
Inside Our Applicants Portal
Access Applicants Portal
- Grants Repository - Access current and historic funding opportunities with ease. Thousands of funding opportunities are published every week. We can help you sort through the database and find the eligible ones to apply for.
- Applicant Video Guides - The grant application process can be challenging to follow. We can help you with intuitive video guides to speed up the process and eliminate errors in submissions.
- Grant Proposal Wizard - We have developed a network of private funding organizations and investors across the United States. We can reach out and submit your proposal to these contacts to maximize your chances of getting the funding you need.
Premium leads for funding administrators, grant writers, and loan issuers
Thousands of people visit our website for their funding needs every day. When a user creates a grant proposal and files for submission, we pass the information on to funding administrators, grant writers, and government loan issuers.
If you manage government grant programs, provide grant writing services, or issue personal or government loans, we can help you reach your audience.
Learn More
Request more information:
Would you like to learn more about this funding opportunity, similar opportunities to "RFA MH 22 150", eligibility, application service, and/or application tips? Submit an inquiry below:
Don't forget to subscribe to our grant alerts mailing list to receive weekly alerts on new and updated grant funding opportunities like this one in your email.
